Crystalline forms of (S) 2 ethylbutyl 2 (((S) (((2R,3S,4R,5R) 5 (4aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4- dihydroxytetrahydrofuran-2 yl)methoxy)(phenoxy)phosphoryl)amino)propanoate
Abstract The present invention relates to novel salts and crystalline forms of (S)-2-ethylbutyl-2-(((S)-(((2R,3S,4R,5R)-5 (4-aminopyrrolo[2,1-fl[1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2 yl)methoxy)(phenoxy)phosphoryl)amino)propanoate (Formula I) for use in treating viral infections...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Abstract The present invention relates to novel salts and crystalline forms of (S)-2-ethylbutyl-2-(((S)-(((2R,3S,4R,5R)-5 (4-aminopyrrolo[2,1-fl[1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2 yl)methoxy)(phenoxy)phosphoryl)amino)propanoate (Formula I) for use in treating viral infections. In some embodiments, the viral infection is caused by a virus selected from the group consisting of Arenaviridae, Coronaviridae, Filoviridae, Flaviviridae, and Paramyxoviridae. FormuilaI |
---|